78 leukemia patients had muscle loss measured free.

Doctors currently judge who is too frail for chemotherapy mostly by impression and age.

Software segmentation reused computed-tomography scans already taken for staging, scoring muscle mass no clinician had measured.

Patients with sarcopenia had lower odds of completing treatment or reaching remission, researchers found.

Sources: Nature